ZG005
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for ZG005, covering 2024-06-14 to 2026-01-05. Get the full timeline:
Most recent: Clinical Trial Update: Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma [Phase 1, Phase 2]